Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus–Associated, Clinical N2 Oropharyngeal Cancer

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang, Jonathan Harris, Richard Wheeler et al. · New England Journal of Medicine · 2010 · 6.5K citations · Full text

Medicine, Oncology, Carcinogenesis +9

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Anil K. Chaturvedi, Eric A. Engels, Ruth M. Pfeiffer et al. · Journal of Clinical Oncology · 2011 · 3.6K citations · Full text

Medicine, Oncology, Cancer Epidemiology +11

Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

Carole Fakhry, William H. Westra, S. Li et al. · JNCI Journal of the National Cancer Institute · 2008 · 2.8K citations · Full text

Medicine, Radiation Oncology, Chemotherapy +13

Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer

Gypsyamber DʼSouza, Aimée R. Kreimer, Raphael P. Viscidi et al. · New England Journal of Medicine · 2007 · 2.7K citations

Medicine, Oncology, Cancer Control +13

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

Peter J. Neumann, Joshua T. Cohen, Milton C. Weinstein · New England Journal of Medicine · 2014 · 2.3K citations

Pharmacy, Health Policy, Pharmacoeconomics +17